Toward Integrative Omics
Cancer is incredibly complex, posing enormous challenges beyond the biological field. Taking a multi-omic approach can help us make sense of this diverse set of diseases – and, ultimately, allow us to better understand ourselves as human beings.
Amanda Hummon |
I started researching colorectal cancer for multiple reasons, but a significant part of my interest was triggered by grief; a member of my immediate family died as a result of metastatic colorectal cancer, despite having the access to the best medical care. I wanted to understand more of what had happened and why.
At a Glance
- No one field of –omics is sufficient to understand cancer; we need to look at not just the genome or the transcriptome, but the metabolome, proteome, lipidome and others too
- Next generation sequencing drives genomic advances, but recent improvements in mass spectrometry are driving proteomics
- To derive the greatest benefit from new technologies, we must use them in conjunction with smart data analysis tools like database searching algorithms
- Other “–omes” are poised at the edge of advancement and will grow exponentially as our ability to analyze the data improves
Enjoy our FREE content!
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE and always will be!
Login if you already created an account
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Pathologist magazine